At the recently concluded BioMedEng23 conference, Queen Mary Bioengineering showcased its prowess and contributions to UK Biomedical Engineering. The two-day event, organised by The Association of Biomedical Engineers, Medical Engineers, and Bioengineers (BioMedEng Association), highlighted remarkable advances in and around the UK biomedical sector.

Prof Karin Hing Awarded the Prestigious BioMedEng Innovation Prize​

Prof Karin Hing, of Queen Mary University of London, was awarded the BioMedEng Innovation Prize for her industry-changing work in synthetic bone graft research. Prof Hing's groundbreaking work, particularly in the development of Inductigraft™ (UK) and AltaPore™ (US), has transformed the field, reducing the need for additional surgeries and thereby reducing patient recovery times. As one of the founding scientists of ApaTech, her vision has led to innovations that have not only been commercially successful but have also made significant contributions to global patient care. Prof. Hing's award is a testament to her outstanding career achievements, which include various accolades such as the Royal Mail Stamp in 2019 and the University Research Impact Award in 2023.

Queen Mary Bioengineering's Significant Presence at BioMedEng23

This year, Queen Mary Bioengineering showcased its strength at BioMedEng23 with 15 oral presentations, 6 poster presentations, and 3 sessions chaired by its esteemed faculty. The sessions revolved around critical areas in biomedical engineering:

Cell/Tissue Engineering chaired by Prof Thomas Iskratsch
Biomedical Imaging and Image Processing chaired by Prof Himadri Gupta
Medical Devices & Implants chaired by Prof Zion Tse

Additionally, Dr Stefaan Verbruggen presented at the conference with his insights on "Embedding EDI in Local Research Culture", a testament to Queen Mary's commitment to Equality, Diversity, and Inclusion.

What Lies Ahead: Queen Mary University of London to Host BioMedEng24 in 2024

As announced during the BioMedEng Association Meeting, Queen Mary University of London will host the upcoming BioMedEng24 on 5-6 September 2024. Queen Mary's upcoming hosting of the conference in 2024 marks a significant return, with 12 years having passed since they last hosted it in 2011. This reaffirms Queen Mary's prominent standing within the national biomedical engineering community. BioMedEng24 will be a great platform for discussions, collaboration, and the dissemination of the latest advancements in biomedical engineering.

On this occasion, Prof Hazel Screen, Head of the School of Engineering and Materials Science, said, "Queen Mary Bioengineering's contribution to BioMedEng23 is a testament to our commitment to research excellence and innovation in the field of biomedical engineering. Hosting BioMedEng24 is not just an honour for Queen Mary, but an attestation to the UK's growing influence in the biomedical sector. We're proud to be at the forefront of this evolution."

For more information on Queen Mary Bioengineering's future events, please visit www.sems.qmul.ac.uk/research/bioengineering